CPMD vs JNJ: Which Stock is Better?

Side-by-side comparison of Cannapharmarx, Inc. and Johnson & Johnson in 2026

Comparison Updated:

CPMD

Cannapharmarx, Inc.

$0.00

JNJ

Johnson & Johnson

$218.21

Key Metrics Comparison

MetricCPMDJNJWinner
Market Cap$3.51M$526.82BJNJ
P/E RatioN/A21.15JNJ
EPS (TTM)$N/A$10.34JNJ
Revenue Growth1.1%0.1%CPMD
Gross Margin-192.1%68.4%JNJ

Analyze CPMD

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CPMD or JNJ a better investment?

Comparing CPMD and JNJ: Cannapharmarx, Inc. has a market cap of $3.51M while Johnson & Johnson has $526.82B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CPMD and JNJ?

CPMD (Cannapharmarx, Inc.) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CPMD or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CPMD or JNJ?

CPMD has higher revenue growth at 1.1% vs 0.1% for JNJ.

Which company is more profitable: CPMD or JNJ?

Johnson & Johnson (JNJ) has higher gross margins at 68.4% compared to -192.1% for CPMD.

Which is the larger company: CPMD or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $526.82B compared to $3.51M for CPMD.

Should I buy CPMD or JNJ in 2026?

Both CPMD and JNJ have investment merit. CPMD trades at $0.00 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CPMD and JNJ stock?

Key differences: Market Cap ($3.51M vs $526.82B), P/E Ratio (N/A vs 21.1x), Revenue Growth (1.1% vs 0.1%), Gross Margin (-192.1% vs 68.4%).

Popular Stock Comparisons